Virus-like particles (VLPs) have become key tools in biology, medicine and even engineering. After their initial use to resolve viral...
25 months ago

In this review article, we focus on the advantages and disadvantages of various VLP-producing platforms, recent advances and technical challenges in VLP...
7 months ago

Virus-like particles (VLPs) are non-infectious self-assembling nanoparticles, useful in medicine and nanotechnology.
104 months ago

Here we report prime editor engineered virus-like particles (PE-eVLPs) that deliver prime editor proteins, prime editing guide RNAs and nicking single guide...
8 months ago

Recombinant virus-like particle-based vaccines are composed of viral structural proteins and mimic authentic native viruses but are devoid...
91 months ago

Here we demonstrate that non-infectious SARS-CoV-2 virus like particles (VLPs) can be assembled by co-expressing the viral proteins S, M and E in mammalian...
45 months ago

Virus-like particles (VLPs) have significant potential as artificial vaccines and drug delivery systems. The ability to control their size...
31 months ago

First identified as the etiological agent behind Acquired Immunodeficiency Syndrome (AIDS) in the early 1980s, HIV-1 has continued to spread...
80 months ago

The pandemic of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused a public health emergency, and research on the...
32 months ago

Chikungunya virus (CHIKV) is an emerging infectious agent that can cause severe disease in humans and against which there is presently no...
176 months ago